January 11, 2023 — In recent years, transcatheter mitral valve replacement (TMVR) treatment and technology has evolved, but procedure-related morbidity remains a concern. A new study published in the ...
Balloon Catheter
This channel includes news and new technology innovations for angioplasty balloon catheters (PTA). These are used in arteries with atherosclerotic lesions to compress the plaque expand the artery lumen to reopen occluded or heavily stenosed atherosclerotic lesions. Balloons are often used in combination with a stent to prop the treated vessel segment open. In addition to plain old balloon angioplasty (POBA), this section includes news about drug-coated balloon (DCB), valvuloplasty balloons and specialty cutting balloon.
-
-
October 18, 2022 — Swiss-based medical technology company MedAlliance has announced it has entered into an agreement with Cordis for an acquisition which includes an initial investment of $35M and ...
-
July 12, 2022 — Biotronik announced the presentation of two studies on the performance of its drug-coated balloon catheter Passeo-18 Lux at this year’s LINC congress in Leipzig, Germany. The BIO REACT ...
-
June 8, 2022 — The first patient has been enrolled in the FDA IDE BTK (Below-the-Knee) SELUTION4BTK clinical trial involving SELUTION SLR, MedAlliance’s novel sirolimus-eluting balloon, just one week ...
March 14, 2023 —MedAlliance has announced enrollment of over 1,000 patients in its ground-breaking SELUTION DeNovo coron ...
March 14, 2023
January 27, 2023 — The first US patient has been enrolled at Medstar Washington Hospital Center in the SELUTION4ISR ...
January 27, 2023
January 19, 2023 — Shockwave Medical, Inc., a pioneer in the development of Intravascular Lithotripsy (IVL) to treat ...
January 19, 2023
January 12, 2023 — Selution SLR, MedAlliance’s novel sirolimus-eluting balloon, has received conditional FDA ...
January 12, 2023
January 11, 2023 — In recent years, transcatheter mitral valve replacement (TMVR) treatment and technology has evolved ...
January 11, 2023
January 2, 2023 — The U.S. Food and Drug Administration (FDA) has approved the BioFreedom Drug Coated Coronary Stent (DC ...
January 02, 2023
January 2, 2023 — The U.S. Food and Drug Administration (FDA) has approved the Stellarex 0.035” OTW Drug-coated ...
January 02, 2023
|
November 28, 2022
November 10, 2022 — A national study led by UBC researchers at the Centre for Cardiovascular Innovation is shedding ...
November 10, 2022
November 3, 2022 — Medtronic, a global leader in medical technology, today announced the results of two clinical studies ...
November 03, 2022
October 28, 2022 — SELUTION SLR, MedAlliance’s novel sirolimus-eluting balloon, has received FDA Investigational Device ...
October 28, 2022
October 18, 2022 — Swiss-based medical technology company MedAlliance has announced it has entered into an agreement ...
October 18, 2022
August 23, 2022 — The first US patient has been enrolled in the FDA SELUTION4BTK (Below-the-Knee) clinical trial ...
August 23, 2022
July 21, 2022 — Robocath, a company that designs, develops and commercializes innovative robotic platforms for the ...
July 22, 2022
July 12, 2022 — Biotronik announced the presentation of two studies on the performance of its drug-coated balloon ...
July 12, 2022© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now